Morning Brew Daily
Boeing’s Big Bounce Back & Ozempic Maker Loses its Lead
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
Episode 637: Neal and Toby chat about Boeing’s strongest quarter yet as it seems to have successfully turned the tides of its performance. Then, Novo Nordisk, the maker of Ozempic and Wegovy, are losing the lead to other competitors and copycat drugs. Also, the AI surge is also causing a surge in electricity bills for the locals who live around these massive data centers. Plus, Uggs are becoming popular footwear for men as celebrities help boost sales.
Build your Range Rover Sport at RangeRover.com/US/Sport
Subscribe to Morning Brew Daily for more of the news you need to start your day. Share the show with a friend, and leave us a review on your favorite podcast app.
Listen to Morning Brew Daily Here: https://www.swap.fm/l/mbd-note
Watch Morning Brew Daily Here: https://www.youtube.com/@MorningBrewDailyShow
00:00 - Tsunami warning
2:40 - Boeing bounces back
8:20 - Novo Nordisk loses its edge
11:50 - AI is making electric bills higher
17:50 - Uggs, they’re for men too!
21:00 - Sprint Finish!
Learn more about your ad choices. Visit megaphone.fm/adchoices